Performance and quality of women's sexual life.
Conditions
Interventions
Intervention 1: Intervention group: The intervention group is the group that takes 200 mg shilajit tablets. Intervention 2: Control group: The control group is the group that will take the placebo.
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Women aged 45-18 years Iranian and living in Tehran Literacy in Persian Husband monogamy and living with the spouse now and during the study Having sex in the last two months(According to the research unit) No known underlying disease (diabetes, hypertension, asthma, heart disease, thyroid, pelvic visceral prolapse, tumor, other medical diseases, hyperlipidemia ...) Do not have mental illness(According to the research unit or file) Couples not addicted to drugs and alcohol(According to the research unit or file) Do not use drugs that affect sexual function in the questionnaire (according to the research unit or file) Have not had a stressful accident in the past month (according to the research unit) Do not have a urinary tract infection (according to a recent research unit or test) No vaginitis, cervicitis, pelvic genital pain disorders, active wound or genital lesion that interferes with sexual intercourse (penetration) (according to the examination and according to the statement of the research unit or file) Has no history of being a rape victim (according to the research unit) Has no history of infertility (according to the research unit) No history of pelvic surgery (colpuraphy or correction according to the research unit or file) Not sensitive to shellac or its compounds (according to the research unit) Not pregnant or breastfeeding (according to the research unit)
Exclusion criteria
Exclusion criteria: Not wanting to stay in the study Do not take Shilajet tablets regularly (use less than 80% of cases) Sensitivity to Shilajet pills or side effects during the study (according to the research unit) Creating an active wound or lesion in the genital area that interferes with sexual intercourse (penetration) during the intervention (according to the research unit) Consumption of drugs affecting sexual function during the intervention (according to the research unit) Experience of a stressful incident during the intervention (according to the research unit) Urinary tract infection, vaginitis, cervicitis, pelvic genital pain disorders, sexual abuse during the intervention (according to the research unit) Pregnancy during the intervention (according to the research unit or a positive pregnancy test)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sexual function. Timepoint: 3 times at intervals of 1 month. Method of measurement: Female Sexual Function Index ( FSFI Questionnaire).;Sexual quality of life-Female. Timepoint: 3 times at intervals of 1 month. Method of measurement: sexual quality of life-Female (SQOL-F) Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactshadab shahali
tarbiat modares university
Outcome results
None listed